GKB65.00

GKB Ophthalmics Limited

· Pharma & Health
₹ CrorePeersFABTECHLAXMIDENTLTARSONSFISCHER
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
Returns
Return on Common Equity-10.47
Return on Assets-5.86
Return on Capital Employed-11.50
Return on Invested Capital-8.91
Margins
EBITDA Margin-3.95
Operating Margin-13.10
Pretax Margin-10.96
Net Income Margin-10.39
FCF Margin-7.06
Additional
Effective Tax Rate5.16
Dvd Payout Ratio-0.05
Sustainable Growth Rate-10.47
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY23 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.